Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,852
datasets available to search
ShareScore release 0.7.1
Dataset results
2,852 results for “Hepatocellular carcinoma”
A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03418922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01798134. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06114251. IPD Sharing: NO. Countries: 0. Publications: 1.
A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05653427. IPD Sharing: YES. Countries: 1. Publications: 0.
Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01833299. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors
ClinicalTrials.gov study NCT04767906. IPD Sharing: YES. Countries: 1. Publications: 0.
Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04947956. IPD Sharing: Not stated. Countries: 0. Publications: 6.
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .
ClinicalTrials.gov study NCT06168357. IPD Sharing: Not stated. Countries: 0. Publications: 7.
A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07138885. IPD Sharing: YES. Countries: 1. Publications: 0.
The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT04961918. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Hepatocellular Carcinoma Surveillance in Cirrhotics
ClinicalTrials.gov study NCT04248816. IPD Sharing: NO. Countries: 1. Publications: 0.
Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03430635. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)
ClinicalTrials.gov study NCT04740307. IPD Sharing: YES. Countries: 9. Publications: 0.
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01271504. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
ClinicalTrials.gov study NCT00687596. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atezolizumab and Bevacizumab with Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06133062. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT02112656. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00508001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo Embolization
ClinicalTrials.gov study NCT05491889. IPD Sharing: NO. Countries: 0. Publications: 3.
Hepatocellular Carcinoma and Rheumatoid Arthritis
ClinicalTrials.gov study NCT02880306. IPD Sharing: YES. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.